Massive/Micro Autoethnography

This book presents the creative, arts-based and educative thinking resulting from a "21 day autoethnography challenge" set of self-guided prompts arising from the large-scale collaborative, creative, and global project to explore Massive and Microscopic Sensemaking during COVId-19 Times. It employs a guiding methodological framework of critical autoethnography, narrating the macro and micro experiences of COVID-19 from a first-person, and critically, culturally-informed perspective.

The book features chapters creatively responding to the 21-day pandemic experiment through digital autoethnographic artworks, writings, and collaborations. It allowed authors to build embodied sensibilities, practice autoethnographic forms of writing and making, and transform personal experiences through the COVID-19 moment into critical understanding of scale, sense-making, and the relationality of humans, nonhumans, and the planet.

Autorentext

Dan Harris is an international expert in creativity studies combining critical theory and creative practice methods. Harris also writes and researches on performance, gender, and diversity. Harris is the series creator and editor of Creativity, Education and the Arts (Palgrave Macmillan), has authored over 100 articles/book chapters and 17 books, in addition to public productions of plays, films and spoken word performances, and has won over $2.9 million in competitive research funding since 2010. Harris is currently an Australian Research Council Future Fellow, and RMIT Vice Chancellor's Senior Research Fellow, and the Director of Creative Agency research lab

Annette N. Markham is Professor at RMIT University in Melbourne, Australia, and Co-Director of the Digital Ethnography Research Centre. She is an internationally recognized scholar of innovative and ethical practice in digital research and design. Her work focuses on facilitating more creative, adaptive, and ethical practice for social research by disrupting the vocabularies around method. She founded the Future Making Research Consortium and has facilitated dozens of arts-based experiments and seminars to build data and digital literacy through critical pedagogy. Her work can be found in multiple academic books and journals.

Mary Elizabeth ("M.E.") Luka is Assistant Professor, University of Toronto and an award-winning producer of digital content for television, exhibition and digital platforms. She examines co-creative production and dissemination in arts, culture and media creative hubs and networks in Canada, UK, USA, and Australia. Dr. Luka is a founding member of the Critical Digital Methods Institute at University of Toronto Scarborough and policy co-lead for Archive/Counter-Archive, a national partnership involving 27 universities and cultural organizations in activating audiovisual archives created by Indigenous Peoples (First Nations, Métis, Inuit), the Black community and People of Colour, womxn, LGBT2Q+ and immigrant communities.

Inhalt

Introduction: Sensemaking in COVID, both massive and microscopic.- 1 Triple AAA Ra(n)ting: A is for... .- 2 Situating the self within a new and future 'normal': sensemaking of COVID through co-production.- 3 Playfully Rethinking the Pandemic's Pivot Imperative.- 4 Painting to Live through Sympoiesis.- 5 Betwixt and between: Finding and losing the self in times of COVID-19.- 6 The politicization of life in reprioritizing life.- 7 Holobiont hosting and anti-hosting patterns.- Road Kill, American Style: A Performative Reflexive Autoethnography Through Embodied Imagination, Photography, and Poetry During COVID-19, March 17-June 30, 2020.- 9 Studio as Liminal Space.- 10 Online and in the Dark: Making Sense of Misinformation and Communities during the Coronavirus Pandemic.- 11 Precariousness/precarity during a pandemic: why 'lockdown' is not a new thing.- 12 Through the Introverted Lens: Making Sense of Local and Global Interpersonal Connections through Walking and Photography.- Conclusion: Global thematics in sensemaking of both the massive and microscopic impacts of COVID-19.